Quick Answer
Connect Biopharma Holdings Ltd reported Earnings Per Share Diluted of $1.00 (loss) per share for the year ending 2025.
- Connect Biopharma Holdings Ltd showed a decrease of -257.1% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Connect Biopharma Holdings Ltd's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Connect Biopharma Holdings Ltd's Earnings Per Share Diluted has grown by 11.5%.
- Historical annual values: Fiscal year 2025: $1.00 (loss) per share | Fiscal year 2024: $0.28 (loss) per share | Fiscal year 2023: $1.13 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: